Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Risk after colon cancer higher for the very fat and very thin

Even after successful treatment for colon cancer, the very obese are about one-third more likely to have their cancer recur and to die prematurely from cancer than those of normal weight, researchers from the University of Chicago and the University of Pittsburgh report in the Nov. 15, 2006, issue of the Journal of the National Cancer Institute.

For patients with stage II or stage III colon cancer, the difference in long-term survival for leaner patients compared to those with a body mass index (BMI) of 35 or greater -- which physicians refer to as "very obese" -- was comparable to the difference between those who had surgery followed by chemotherapy and those who had only surgery.

The very thin, those with a BMI less than 18.5, were also at increased risk of death, primarily from other cancers, including respiratory cancers possibly connected to smoking, as well as non-cancer causes.

"Given the increasing proportion of Americans with a BMI greater than 35 and the fact that these individuals are over-represented among colon cancer patients, we need to find out why extra weight has such a harmful impact and come up with new ways to counter that," said study author James Dignam, Ph.D., a biostatistician and assistant professor in the Department of Health Studies at the University of Chicago.

"One first step would be to investigate whether modifying diet and exercise habits for patients after treatment would have a positive impact on colon cancer outcomes," he said. "Other studies beginning to explore the effect exercise in colon and other cancers have been promising."

The researchers studied data from 4,288 patients with stage II or stage III colon cancer who enrolled in either of two multi-center clinical trials between July 1989 and February 1994. Both trials, administered by the National Surgical Adjuvant Breast and Bowel Project, headquartered at the University of Pittsburgh, compared different regimens of chemotherapy following surgery. Median follow-up from surgery to last contact with patients who were still alive was 11.2 years.

More than half of the patients in the trial (54%) were overweight and 5.5 percent were very obese. About three percent were underweight.

The researchers focused on the relationship between body mass index at the time of diagnosis and long-term prognosis. They found that the risk of death was increased "at both ends of the adiposity spectrum."

Patients who were very obese were most likely to die from colon cancer recurrence. Patients who were underweight had twice the risk of death, but their increased risk was from non-colon cancer-related causes.

The mechanism connecting excess weight to cancer recurrence and death "is not completely understood," the authors note. Previous studies have suggested a role for insulin, insulin-like growth factors, the hormones that regulate hunger and other obesity-related pathways. Another possibility is the presence of concurrent illnesses associated with obesity, which may interfere with the ability to deliver effective treatment.

"This study provides us with an easy way to predict that certain patients have a higher risk of recurrence and thus might benefit from closer surveillance and additional interventions," said Dignam.

John Easton | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>